Big Pharma Needs New Drugs. China Has Them

Big Pharma is increasingly looking to China as a source of potential blockbuster drugs, signaling a strategic shift in global drug discovery and licensing. The trend could expand patient access to new therapies and increase competitive pressure on U.S. biotech companies, with implications for the long-term leadership of the U.S. biotechnology ecosystem.